<- Go Home
Daewoong Pharmaceutical Co., Ltd
Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.
Market Cap
KRW 1.7T
Volume
40.5K
Cash and Equivalents
KRW 94.6B
EBITDA
KRW 183.9B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
KRW 724.5B
Profit Margin
51.15%
52 Week High
KRW 164.4K
52 Week Low
KRW 100.1K
Dividend
N/A
Price / Book Value
2.02
Price / Earnings
15.97
Price / Tangible Book Value
3.39
Enterprise Value
KRW 2.3T
Enterprise Value / EBITDA
10.19
Operating Income
KRW 136.5B
Return on Equity
10.75%
Return on Assets
4.70
Cash and Short Term Investments
KRW 107.5B
Debt
KRW 618.2B
Equity
KRW 951.4B
Revenue
KRW 1.4T
Unlevered FCF
-KRW 165.4B
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium